Dora Mitchell | Founder
Aleko Therapeutics, Inc.

Biotechnology executive with twenty years of experience transforming early scientific innovation into venture-backed, clinical-stage companies and exit-ready assets. Proven operator and strategic partner to CEOs and Boards, with deep expertise spanning company formation, capital raising, operations, governance, business and laboratory infrastructure.  Recognized for disciplined decision-making and delivery of value-creating inflection points. Track record includes launching over 20 startups, raising multi-stage financing, building companies through exit, and serving in senior leadership and board roles across academia, venture capital, and industry.